Affinities of bispyridinium non-oxime compounds to [(3)H]epibatidine binding sites of Torpedo californica nicotinic acetylcholine receptors depend on linker length.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Chemico-Biological Interactions

• Publication date

  2013-12-05

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.cbi.2013.10.012PMID 24157926
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Binding Interactions with the Complementary Subunit of Nicotinic Receptors*

  2013cited by this paper
• Nicotinic acetylcholine receptors: from basic science to therapeutics.

  2013cited by this paper
• Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands

  2013cited by this paper
• Restoration of soman-blocked neuromuscular transmission in human and rat muscle by the bispyridinium non-oxime MB327 in vitro.

  2012cited by this paper
• 1,1′-(Propane-1,3-diyl)bis(4-tert-butylpyridinium) di(methanesulfonate) protects guinea pigs from soman poisoning when used as part of a combined therapy

  2012cited by this paper
• Competition radioligand binding assays for the investigation of bispyridinium compound affinities to the human muscarinic acetylcholine receptor subtype 5 (hM(5) ).

  2012cited by this paper
• Protection against nerve agent poisoning by a noncompetitive nicotinic antagonist.

  2011cited by this paper
• Interaction of bispyridinium compounds with the orthosteric binding site of human α7 and Torpedo californica nicotinic acetylcholine receptors (nAChRs).

  2011cited by this paper
• Assessment of neuromuscular dysfunction during poisoning by organophosphorus compounds.

  2010cited by this paper
• Nicotinic acetylcholine receptors: an overview on drug discovery

  2009cited by this paper
• Interaction of benzylidene‐anabaseine analogues with agonist and allosteric sites on muscle nicotinic acetylcholine receptors

  2009cited by this paper
• Mammalian nicotinic acetylcholine receptors: from structure to function.

  2009cited by this paper
• Conformational changes in α7 acetylcholine receptors underlying allosteric modulation by divalent cations

  2009cited by this paper
• [3H]Epibatidine Photolabels Non-equivalent Amino Acids in the Agonist Binding Site of Torpedo and α4β2 Nicotinic Acetylcholine Receptors*

  2009cited by this paper
• Epibatidine binds to four sites on the Torpedo nicotinic acetylcholine receptor.

  2008cited by this paper
• Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.

  2007cited by this paper
• Quaternary ammonium anticholinesterases have different effects on nicotinic receptors

  2007cited by this paper
• Muscle and neuronal nicotinic acetylcholine receptors

  2007cited by this paper
• Diverse inhibitory actions of quaternary ammonium cholinesterase inhibitors on Torpedo nicotinic ACh receptors transplanted to Xenopus oocytes

  2007cited by this paper
• Miniaturized Receptor Binding Assays: Complications Arising from Ligand Depletion

  2007cited by this paper
• Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity.

  2007cited by this paper
• Chain length dependence of the interactions of bisquaternary ligands with the Torpedo nicotinic acetylcholine receptor.

  2007cited by this paper
• Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents

  2006cited by this paper
• Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model.

  2005cited by this paper
• Nicotinic acetylcholine receptor ligands as potential therapeutics

  2005cited by this paper
• Using physical chemistry to differentiate nicotinic from cholinergic agonists at the nicotinic acetylcholine receptor.

  2005cited by this paper
• Nicotinic antagonists in the treatment of nerve agent intoxication.

  2005cited by this paper
• Fluorinated pyridine derivatives: Part 1. The synthesis of some mono- and bis-quaternary pyridine salts of potential use in the treatment of nerve agent poisoning

  2005cited by this paper
• Mechanism of action of HI-6 on soman inhibition of acetylcholinesterase in preparations of rat and human skeletal muscle; comparison to SAD-128 and PAM-2

  2004cited by this paper
• Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures.

  2004cited by this paper
• Therapy for nerve agent poisoning.

  2004cited by this paper
• Bisquaternary caracurine V and iso-caracurine V salts as ligands for the muscle type of nicotinic acetylcholine receptors: SAR and QSAR studies.

  2004cited by this paper
• Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes.

  2004cited by this paper
• Nicotinic acetylcholine receptors as drug targets.

  2004cited by this paper
• Assembly and subunit diversity of nicotinic acetylcholine receptors.

  2003cited by this paper
• Regulation of Nicotinic Acetylcholine Receptor Assembly

  2003cited by this paper
• Molar absorption coefficients for the reduced Ellman reagent: reassessment.

  2003cited by this paper
• Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates

  2002cited by this paper
• bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptors.

  2002cited by this paper
• Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation

  2002cited by this paper
• Cation-pi interactions in ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine.

  2002cited by this paper
• Allosterically linked noncompetitive antagonist binding sites in the resting nicotinic acetylcholine receptor ion channel.

  2002cited by this paper
• bis-azaaromatic quaternary ammonium analogues: Ligands for α4β2* and α7* subtypes of neuronal nicotinic receptors

  2002cited by this paper
• Open channel and competitive block of nicotinic receptors by pancuronium and atracurium.

  2001cited by this paper
• The kinetics of inhibition of nicotinic acetylcholine receptors by (+)-tubocurarine and pancuronium.

  2001cited by this paper
• Improved determination of acetylcholinesterase activity in human whole blood.

  1999cited by this paper
• Identification of calcium binding sites that regulate potentiation of a neuronal nicotinic acetylcholine receptor.

  1996cited by this paper
• Structural bases for the specificity of cholinesterase catalysis and inhibition.

  1995cited by this paper
• Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase.

  1994cited by this paper
• Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro

  1993cited by this paper
• Organophosphate poisoning.

  1993cited by this paper
• Rational experimental design and data analysis for ligand binding studies: tricks, tips and pitfalls.

  1993cited by this paper
• Rational experimental design and data analysis for ligand binding studies: tricks, tips and pitfalls.

  1993cited by this paper
• Actions of a series of bisquaternary compounds on nicotinic acetylcholine receptors in insects: ligand binding and electrophysiological studies.

  1992cited by this paper
• Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors.

  1992cited by this paper
• Potentiation of nicotinic receptor response by external calcium in rat central neurons.

  1992cited by this paper
• A contribution to the mechanism of action of SAD-128.

  1990cited by this paper
• The nonoxime bispyridinium compound SAD-128 alters the kinetic properties of the nicotinic acetylcholine receptor ion channel: a possible mechanism for antidotal effects.

  1989cited by this paper
• The historical significance of work with electric organs for the study of cholinergic transmission.

  1989cited by this paper
• Adaptation of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions.

  1986cited by this paper
• Primary structures of the catalytic subunits from two molecular forms of acetylcholinesterase. A comparison of NH2-terminal and active center sequences.

  1985cited by this paper
• Measurement of protein using bicinchoninic acid.

  1985cited by this paper
• Agonist interactions with cardiac muscarinic receptors. Effects of Mg2+, guanine nucleotides, and monovalent cations.

  1985cited by this paper
• A rapid filtration assay for soluble receptors using polyethylenimine-treated filters.

  1983cited by this paper
• Radiolabeled alpha-bungarotoxin derivatives: kinetic interaction with nicotinic acetylcholine receptors.

  1981cited by this paper
• Adsorption of divalent cations to bilayer membranes containing phosphatidylserine

  1981cited by this paper
• Purification of Torpedo californica post-synaptic membranes and fractionation of their constituent proteins.

  1980cited by this paper
• Effects of 1,1'-oxydimethylene bis-(4-tert-butylpyridinium chloride) (SAD-128) and decamethonium on reactivation of soman- and sarin-inhibited cholinesterase by oximes.

  1978cited by this paper
• The adsorption of divalent cations to phosphatidylcholine bilayer membranes.

  1978cited by this paper
• Decamethonium both opens and blocks endplate channels.

  1978cited by this paper
• Large-scale purification of the acetylcholine-receptor protein in its membrane-bound and detergent-extracted forms from Torpedo marmorata electric organ.

  1977cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• [Efficacy of pyridinium salts in tabun and sarin poisoning in vivo and in vitro].

  1973cited by this paper
• The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes.

  1963cited by this paper

• Characterization of cell membrane fragments containing muscle type nAChR from Tetronarce californica after preparation using high pressure homogenization.

  2025cites this paper
• The synthesis and influence of the novel bispyridinium compound LB1 on the effectiveness of the standard antidotal treatment of organophosphorus nerve agent intoxicated mice and some structure-activity considerations.

  2025cites this paper
• Development of a Scintillation Proximity Assay for [3H]epibatidine binding sites of Tetronarce californica muscle-type nicotinic acetylcholine receptor.

  2024cites this paper
• Identification of ligands binding to MB327-PAM-1, a binding pocket relevant for resensitization of nAChRs

  2023cites this paper
• A novel binding site in the nicotinic acetylcholine receptor for MB327 can explain its allosteric modulation relevant for organophosphorus-poisoning treatment.

  2023cites this paper
• Influence of Experimental End Point on the Therapeutic Efficacy of Essential and Additional Antidotes in Organophosphorus Nerve Agent-Intoxicated Mice

  2022cites this paper
• Molecular determinants of binding of non-oxime bispyridinium nerve agent antidote compounds to the adult muscle nAChR.

  2021cites this paper
• Influence of experimental end point on the therapeutic efficacy of the antinicotinic compounds MB408, MB442 and MB444 in treating nerve agent poisoned mice – a comparison with oxime-based treatment

  2020cites this paper
• Diagnostics and treatment of nerve agent poisoning—current status and future developments

  2020cites this paper
• Human small bowel as model for poisoning with organophosphorus compounds.

  2019cites this paper
• Spectroscopic, structural and theoretical investigation of 1,3-bis(3-hydroxymethylpyridinium)propane dibromide, tetrabromozincate and tetrabromocuprate

  2018cites this paper
• Some benefit from non-oximes MB408, MB442 and MB444 in combination with the oximes HI-6 or obidoxime and atropine in antidoting sarin or cyclosarin poisoned mice.

  2018cites this paper
• Synthesis of a Series of Structurally Diverse MB327 Derivatives and Their Affinity Characterization at the Nicotinic Acetylcholine Receptor

  2018cites this paper
• Spectroscopic and DFT studies of bis-3-hydroxypyridinium and bis-3-hydroxymethylpyridinium dibromides with tetramethylene linker.

  2018cites this paper
• Electrophysiological investigation of the effect of structurally different bispyridinium non-oxime compounds on human α7-nicotinic acetylcholine receptor activity-An in vitro structure-activity analysis.

  2017cites this paper
• Human small bowel as a useful tool to investigate smooth muscle effects of potential therapeutics in organophosphate poisoning.

  2017cites this paper
• Development of MS Binding Assays targeting the binding site of MB327 at the nicotinic acetylcholine receptor.

  2017cites this paper
• In vitro pharmacological characterization of the bispyridinium non-oxime compound MB327 and its 2- and 3-regioisomers.

  2017cites this paper
• Searching for putative binding sites of the bispyridinium compound MB327 in the nicotinic acetylcholine receptor.

  2017cites this paper
• Oximes in organophosphate poisoning: 60 years of hope and despair.

  2016cites this paper
• Pharmacokinetic profile and quantitation of protection against soman poisoning by the antinicotinic compound MB327 in the guinea-pig.

  2016cites this paper
• Evaluation of the benefit of the bispyridinium compound MB327 for the antidotal treatment of nerve agent-poisoned mice

  2016cites this paper
• Functional analysis of Torpedo californica nicotinic acetylcholine receptors in multiple activation states by SSM-based electrophysiology.

  2016cites this paper
• The protective role of tacrine and donepezil in the retina of acetylcholinesterase knockout mice.

  2015cites this paper
• Structural and molecular determinants of the sensitivity of α4β2 nicotinic acetylcholine receptors to the allosteric ligand desformylflustrabromine

  2015cites this paper